Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Coates

Showing results (281-290 of 574) with videos related to

Pageof 58
Sort By:
Academic Medicine : Journal of the Association of American Medical Colleges|November 3, 2016
Creating a Cadre of Fellowship-Trained Medical Educators, Part II: A Formal Needs Assessment to Structure Postgraduate Fellowships in Medical Education Scholarship and LeadershipJaime Jordan, Lalena M Yarris, Sally A Santen, et al.
Rheumatology (Oxford, England)|October 18, 2024
Deucravacitinib, a selective, TYK2 inhibitor, in psoriatic arthritis: achievement of minimal disease activity components in a phase 2 trialArthur Kavanaugh, Laura C Coates, Philip J Mease, et al.
BMJ Open|April 23, 2024
Qualitative interview study of rheumatology patients' experiences of COVID-19 shielding to explore the physical and psychological impact and identify associated support needsChristine A Silverthorne, Bethan Jones, Mel Brooke, et al.
Clinical Rheumatology|July 12, 2022
Correction to: Efficacy and safety of ixekizumab in patients with active psoriatic arthritis with and without concomitant conventional disease-modifying antirheumatic drugs: SPIRIT-P1 and SPIRIT-P2 3-year resultsLaura C Coates, Philip Mease, Andris Kronbergs, et al.
The Plant Cell|July 9, 2009
Shoot Na+ exclusion and increased salinity tolerance engineered by cell type-specific alteration of Na+ transport in ArabidopsisInge S Møller, Matthew Gilliham, Deepa Jha, et al.
Rheumatology Advances in Practice|April 24, 2023
The impact of comorbidities on interleukin-17 inhibitor therapy in psoriatic arthritis: a Danish population-based cohort studyMagnus B Petersen, Rebekka L Hansen, Alexander Egeberg, et al.
Biological Research for Nursing|October 8, 2024
Impact of Polypharmacy on Symptoms and Health Outcomes in Older Adults With and Without Alzheimer's Disease and Related DementiasMartha C Coates, Leslie A McClure, Daniel Vader, et al.
The Western Journal of Emergency Medicine|April 10, 2024
Development and Validation of a Scoring Rubric for Editorial Evaluation of Peer-review Quality: A Pilot StudyJeffrey N Love, Anne M Messman, Jonathan S Ilgen, et al.
Therapeutic Advances in Musculoskeletal Disease|January 17, 2022
Clinical effectiveness of symptomatic therapy compared with standard step-up care for the treatment of low-impact psoriatic oligoarthritis: the two-arm parallel group randomised POISE feasibility studyInes Rombach, Laura Tucker, William Tillett, et al.
Rheumatology (Oxford, England)|January 13, 2017
New GRAPPA and EULAR recommendations for the management of psoriatic arthritisLaura C Coates, Laure Gossec, Sofia Ramiro, et al.
Pageof 58

Showing results (281-290 of 574) with videos related to

Sort By:
Pageof 58
Academic Medicine : Journal of the Association of American Medical Colleges|November 3, 2016
Creating a Cadre of Fellowship-Trained Medical Educators, Part II: A Formal Needs Assessment to Structure Postgraduate Fellowships in Medical Education Scholarship and LeadershipJaime Jordan, Lalena M Yarris, Sally A Santen, et al.
Rheumatology (Oxford, England)|October 18, 2024
Deucravacitinib, a selective, TYK2 inhibitor, in psoriatic arthritis: achievement of minimal disease activity components in a phase 2 trialArthur Kavanaugh, Laura C Coates, Philip J Mease, et al.
BMJ Open|April 23, 2024
Qualitative interview study of rheumatology patients' experiences of COVID-19 shielding to explore the physical and psychological impact and identify associated support needsChristine A Silverthorne, Bethan Jones, Mel Brooke, et al.
Clinical Rheumatology|July 12, 2022
Correction to: Efficacy and safety of ixekizumab in patients with active psoriatic arthritis with and without concomitant conventional disease-modifying antirheumatic drugs: SPIRIT-P1 and SPIRIT-P2 3-year resultsLaura C Coates, Philip Mease, Andris Kronbergs, et al.
The Plant Cell|July 9, 2009
Shoot Na+ exclusion and increased salinity tolerance engineered by cell type-specific alteration of Na+ transport in ArabidopsisInge S Møller, Matthew Gilliham, Deepa Jha, et al.
Rheumatology Advances in Practice|April 24, 2023
The impact of comorbidities on interleukin-17 inhibitor therapy in psoriatic arthritis: a Danish population-based cohort studyMagnus B Petersen, Rebekka L Hansen, Alexander Egeberg, et al.
Biological Research for Nursing|October 8, 2024
Impact of Polypharmacy on Symptoms and Health Outcomes in Older Adults With and Without Alzheimer's Disease and Related DementiasMartha C Coates, Leslie A McClure, Daniel Vader, et al.
The Western Journal of Emergency Medicine|April 10, 2024
Development and Validation of a Scoring Rubric for Editorial Evaluation of Peer-review Quality: A Pilot StudyJeffrey N Love, Anne M Messman, Jonathan S Ilgen, et al.
Therapeutic Advances in Musculoskeletal Disease|January 17, 2022
Clinical effectiveness of symptomatic therapy compared with standard step-up care for the treatment of low-impact psoriatic oligoarthritis: the two-arm parallel group randomised POISE feasibility studyInes Rombach, Laura Tucker, William Tillett, et al.
Rheumatology (Oxford, England)|January 13, 2017
New GRAPPA and EULAR recommendations for the management of psoriatic arthritisLaura C Coates, Laure Gossec, Sofia Ramiro, et al.
Pageof 58